Ke halaman utama
820К+ pasien telah mendapatkan bantuan sejak 2014
50 negara
1,500 klinik
6K+ ulasan
3K+ dokter berkualifikasi

Berapa Biaya Prosedur Diagnostik dan Perawatan Karsinomatosis di Índia? Cari Tahu Sekarang

Harga rata-rata untuk diagnosis dan perawatan Karsinomatosis di Índia adalah $18,500, harga minimum $17,000, dan harga maksimum $20,000.
Data diverifikasi oleh Bookimed per June 2026, berdasarkan permintaan pasien dan penawaran resmi dari 64 klinik di seluruh dunia. Biaya median didasarkan pada faktur nyata (2025–2026) dan diperbarui setiap bulan. Harga aktual dapat bervariasi.

Keuntungan dan Jaminan Anda bersama Bookimed

Harga Langsung

Bookimed tidak menambah biaya tambahan dalam harga perawatan Karsinomatosis. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik saat tiba di negara tujuan untuk perawatan Anda.

Hanya Klinik & Dokter Terverifikasi

Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam perawatan Karsinomatosis dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.

Bantuan Gratis 24/7

Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan perawatan Karsinomatosis Anda.

Mengapa kami?

Asisten pribadi Bookimed Anda

  • Mendukung Anda di setiap tahap
  • Membantu memilih klinik dan dokter yang tepat
  • Memastikan akses informasi yang cepat dan mudah

Temukan Klinik Karsinomatosis Terbaik di Índia: 8 Opsi Terverifikasi dan Harga

Klinik diperingkat oleh sistem cerdas Bookimed menggunakan analisis data science pada 5 kriteria utama.
Artemis Hospitals
Manipal Hospitals
Global Hospital Chennai
Global Hospital Mumbai

Dapatkan Pemeriksaan Medis untuk Karsinomatosis di Índia: Konsultasi dengan Dokter Berpengalaman Sekarang

Lihat semua Dokter
terverifikasi

Raj Nagarkar

30 tahun pengalaman

Dr. Raj telah melakukan 50.000+ operasi kanker selama lebih dari 19 tahun, dengan spesialisasi Bedah Onkologi Payudara dan Toraks di HCG Manavata Cancer Centre.

  • Menjalani pelatihan di Tata Memorial Hospital dan Royal College of Surgeons, Edinburgh
  • Terlibat dalam 200+ uji klinis, termasuk studi fase 1-3
  • Profesor untuk Subspesialisasi DNB Bedah Onkologi dan Bedah Payudara
  • Berfokus pada peningkatan kualitas hidup pasien di samping pengobatan
terverifikasi

Shruti Kate

15 tahun pengalaman

Dr. Shruti Kate berspesialisasi dalam pengobatan kanker tingkat lanjut, termasuk imunoterapi dan terapi metronomik. Ia dilatih di Tata Memorial Hospital – pusat kanker terkemuka di India.

  • Menjadi ahli dalam kanker paru-paru, payudara, dan ginekologi
  • Menjadi anggota ASCO, ESMO, dan perkumpulan onkologi terkemuka lainnya
  • Mempresentasikan penelitian kanker paru-paru di Konferensi Kanker Paru-paru Dunia
  • Menggunakan pendekatan inovatif untuk kasus kanker stadium lanjut
terverifikasi

Chaitainya Borde

11 tahun pengalaman

Menangani lebih dari 30.000 pemindaian PET dan 1.000 pasien kanker tiroid – Dr. Borde adalah spesialis kedokteran nuklir di HCG Manavata Cancer Centre.

  • 12 tahun pengalaman dalam kedokteran nuklir
  • Mahir dalam terapi radioiodine dan Lu-177 RN
  • Ahli dalam semua jenis pemindaian nuklir dan PET-CT
  • Menerbitkan karya ilmiah di berbagai jurnal medis

Bagikan konten ini

Video Kisah dari Pasien Bookimed

Dayana
I combined my vacation in Antalya with a check-up.
Prosedur: Pemeriksaan kesehatan wanita
Igor
It was great! Transfers, accommodation, treatment—all included.
Prosedur: Implan Gigi
Marina
Bookimed did everything for me. I didn't have to worry about anything.
Prosedur: Pemeriksaan kesehatan wanita
Diperbarui: 05/27/2022
Ditulis oleh
Anna Leonova
Anna Leonova
Head of Content Marketing Team
Penulis medis bersertifikat dengan pengalaman 10+ tahun, membangun konten tepercaya Bookimed, didukung Master di bidang Filologi dan wawancara ahli medis di seluruh dunia.
Fahad Mawlood
Editor Medis & Data Scientist
Dokter umum. Pemenang 4 penghargaan ilmiah. Pernah bertugas di Asia Barat. Mantan Pemimpin Tim tim medis yang mendukung pasien berbahasa Arab. Kini bertanggung jawab atas pengolahan data dan akurasi konten medis.
Fahad Mawlood Linkedin
Halaman ini mungkin menampilkan informasi terkait berbagai kondisi medis, perawatan, dan layanan kesehatan yang tersedia di berbagai negara. Perhatian: konten ini hanya untuk tujuan informasi dan tidak boleh diartikan sebagai nasihat atau panduan medis. Harap konsultasikan dengan dokter atau tenaga medis profesional sebelum memulai atau mengubah perawatan medis.

FAQ tentang Pengobatan Karsinomatosis di Índia

FAQ ini berasal dari pasien nyata yang mencari bantuan medis melalui Bookimed. Jawaban diberikan oleh koordinator medis berpengalaman dan perwakilan klinik terpercaya.

Who is an ideal candidate for CRS and HIPEC treatment?

Ideal candidates for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have advanced cancer confined strictly to the abdominal cavity. Patients must demonstrate high physical fitness to endure multisour procedures. Surgeons must be able to achieve complete removal of all visible tumor masses.

  • Tumor location: Disease must remain localized within the peritoneal cavity without spreading elsewhere.
  • Primary cancer types: Most favorable for appendix cancer, pseudomyxoma peritonei, and colorectal or ovarian cancers.
  • Surgical feasibility: Specialists use CT or PET-CT to ensure complete resection is achievable.
  • Physical health: Patients require strong cardiac and renal function for intensive 8–12 hour operations.

Bookimed Expert Insight: Indian centers like Global Hospital Chennai and HCG Manavata Cancer Centre use PET-CT and diagnostic laparoscopy to avoid surgical surprises. Data shows that high-volume clinics treating 75,000+ patients annually apply stricter selection criteria. This rigor often leads to higher success in achieving complete cytoreduction.

Patient Consensus: Patients emphasize that specialized peritoneal surgeons may find cases operable even when general oncologists are hesitant. Many suggest that maintaining mobility and nutrition before the evaluation significantly improves the chances of being accepted for treatment.

What is the success rate of Carcinomatosis treatment in India?

Success rates for carcinomatosis treatment in India show a 60–80% histological response when using Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). Advanced centers also achieve improved survival through cytoreductive surgery combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Outcomes depend on the primary cancer type and disease extent.

  • Response rates: PIPAC technology achieves 60–80% cancer cell reduction in peritoneal cases.
  • Survival outcomes: Advanced ovarian carcinomatosis shows approximate 10-year survival rates of 15–30%.
  • Treatment focus: Specialists combine aggressive surgery with HIPEC to control stage IV spread.
  • Center expertise: Accredited facilities like Artemis and Manipal provide protocol-based, multidisciplinary care.

Bookimed Expert Insight: Success in treating carcinomatosis in India often correlates with the high surgical volumes of leading oncologists. Dr. Raj Nagarkar at HCG Manavata has performed over 50,000 cancer surgeries. This level of experience is vital because surgical candidacy—the biggest factor in long-term survival—is often determined during the operation itself. India’s largest centers, serving up to 2,000,000 patients annually, offer the specialized infrastructure necessary for these complex 8–12 hour procedures.

Patient Consensus: Patients note that success often means long-term disease control rather than a full cure. Many emphasize seeking second opinions from tertiary centers to confirm if they are candidates for HIPEC surgery.

Does health insurance cover advanced carcinomatosis treatments in India?

Health insurance in India covers advanced carcinomatosis treatments through indemnity policies or critical illness plans. Coverage includes modern procedures like HIPEC (Hyperthermic Intraperitoneal Chemotherapy). IRDAI regulations mandate that insurers cover advanced therapies, robotic surgeries, and targeted chemotherapy under modern treatment clauses.

  • Modern treatments: Modalities like HIPEC receive partial or full coverage under IRDAI mandates.
  • Hospitalization limits: Major tumor debulking surgeries are covered up to the specific sum insured.
  • Waiting periods: Critical illness plans typically require a 90-day waiting period before claim eligibility.
  • Policy exclusions: Expenses for specialized disposables or experimental drugs may require out-of-pocket payments.

Bookimed Expert Insight: While major centers like Artemis Hospitals or Manipal Hospitals hold JCI and NABH accreditations, insurance payouts often depend on facility categorization. High-volume centers like Global Hospital Chennai serve 80,000 patients annually, making them more likely to have established cashless desks. Choosing a JCI-accredited hospital usually ensures more standardized billing for complex oncology claims.

Patient Consensus: Patients note that coverage is often partial. Pre-authorization is essential because insurers may label parts of high-cost surgical care as investigational or elective after discharge.

What is the recovery timeline after receiving CRS and HIPEC?

Recovery after CRS and HIPEC in India usually takes 3 to 6 months. Patients typically spend 7 to 14 days in specialized oncology centers like Global Hospital or Artemis. Full physiological return to pre-operative levels often requires up to 1 year for extensive peritonectomy cases.

  • Hospital stay: Expect 1–3 weeks depending on bowel function and primary wound healing.
  • Initial phase: Fatigue and digestive changes are common during the first 2 months.
  • Activity resumption: Most patients return to light work or tasks after about 8 weeks.
  • Full stamina: Normal energy levels and appetite typically return 6 months after surgery.

Bookimed Expert Insight: Indian oncology centers like HCG Manavata feature high-volume surgeons such as Dr. Raj Nagarkar, who has performed over 50,000 surgeries. Data suggests that choosing high-volume specialists is vital for HIPEC, as `stunned` bowel recovery depends heavily on intraoperative precision and post-operative nutritional management. In India, some facilities also use IBM Watson to tailor recovery protocols specifically to the patient’s unique tumor biology.

Patient Consensus: Patients note that recovery happens in 2 stages: first leaving the hospital, then slowly rebuilding nutrition and weight over several months. Many emphasize that having help at home for the first few weeks is essential as stamina returns very gradually.

Which hospitals in India are well-equipped for Carcinomatosis treatment?

Indian oncology centers provide specialized treatment for carcinomatosis through cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Major facilities in Gurugram, Mumbai, and Chennai maintain National Accreditation Board for Hospitals and Healthcare Providers (NABH) standards. Leading units utilize multidisciplinary tumor boards to manage advanced peritoneal malignancies.

  • Specialized infrastructure: Facilities like Artemis Hospitals and Medanta hold Joint Commission International accreditation.
  • Advanced technology: Dr. Rela Institute uses linear accelerators with 1 mm precision for targeting.
  • Nuclear medicine: HCG Manavata Cancer Centre has managed over 30,000 PET-CT scans for staging.
  • Experience levels: Top surgeons like Dr. Raj Nagarkar have performed over 50,000 cancer surgeries.

Bookimed Expert Insight: While many general hospitals offer oncology, focusing on centers with high-volume peritoneal surface departments is essential. For instance, HCG Manavata Cancer Centre has treated over 100,000 global patients. This high volume often correlates with refined surgical protocols for complex cytoreductive procedures. Clinics like Manipal Goa even integrate IBM Watson to assist in selecting precise treatment paths.

Patient Consensus: Patients emphasize choosing clinics where surgery, radiology, and ICU support coexist in one building. They also recommend bringing original pathology slides for a second opinion before starting intensive HIPEC protocols.

Dapatkan konsultasi gratis

Pilih cara terbaik agar kami menghubungi Anda